SCHEMBL872744

SCHEMBL872744

CC(C)COC(=O)CCc1ccco1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.47
POLB P06746 4/20 0.46
MAPT P10636 4/20 0.46
HPGD P15428 3/20 0.46
USP2 O75604 1/20 0.46
TSHR P16473 1/20 0.42
GAA P10253 1/20 0.42
LMNA P02545 1/20 0.41
TP53 P04637 3/20 0.40
ADORA2B P29275 1/20 0.40
L3MBTL1 Q9Y468 3/20 0.39
ESR1 P03372 2/20 0.39
APEX1 P27695 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
ALOX15 P16050 1/20 0.39
RECQL P46063 1/20 0.39
BLM P54132 1/20 0.39
HSD17B10 Q99714 1/20 0.39
CTDSP1 Q9GZU7 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28249440 0.90 MAPT (0.49) ALDH1A1MAPTLMNATDP1RECQL
SCHEMBL1532438 0.85 ALDH1A1 (0.45) ALDH1A1POLBMAPTHPGDUSP2
Isobutyl Cinnamate SCHEMBL28249487 0.85 ALDH1A1 (0.46) ALDH1A1POLBMAPTHPGDLMNA
SCHEMBL64663 0.83 ALDH1A1 (0.51) ALDH1A1POLBMAPTHPGDUSP2
SCHEMBL28218075 0.80 ALDH1A1 (0.49) ALDH1A1POLBMAPTHPGDUSP2
SCHEMBL5883913 0.79 ALDH1A1 (0.50) ALDH1A1POLBMAPTHPGDTSHR
SCHEMBL4236122 0.77 ALDH1A1 (0.43) ALDH1A1POLBMAPTHPGDGAA
SCHEMBL27487267 0.77 POLB (0.45) ALDH1A1POLBMAPTHPGDL3MBTL1
SCHEMBL21729748 0.76 KMT2A (0.48) ALDH1A1POLBMAPTHPGDUSP2
SCHEMBL8334989 0.76 ALDH1A1 (0.59) ALDH1A1POLBMAPTHPGDUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 115 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250302678-A1 ABSORBENT ARTICLES INCLUDING PERFUME AND CYCLODEXTRINS PROCTER & GAMBLE (US) 2025-10-02 US claimed
US-12350136-B2 Absorbent articles including perfume and cyclodextrins THE PROCTER & GAMBLE COMPANY (US) 2025-07-08 US claimed
EP-4257663-A1 FOOD CONTACT SURFACE SANITIZING LIQUID The Procter & Gamble Company (US) 2023-10-11 EP claimed
US-20220401275-A1 ABSORBENT ARTICLES INCLUDING PERFUME AND CYCLODEXTRINS PROCTER & GAMBLE (US) 2022-12-22 US claimed
US-11458049-B2 Absorbent articles including perfume and cyclodextrins THE PROCTER & GAMBLE COMPANY (US) 2022-10-04 US claimed
EP-3809876-A1 PROTECTIVE AGENT FOR FOOD PRODUCTS AND THE LIKE AND FOR CURING AND/OR STORAGE ROOMS OF THE SAME PERPRIN S.R.L. (IT) 2021-04-28 EP claimed
EP-3509647-B1 ABSORBENT ARTICLES INCLUDING PERFUME AND CYCLODEXTRINS PROCTER & GAMBLE (US) 2020-10-21 EP claimed
WO-2019243869-A1 PROTECTIVE AGENT FOR FOOD PRODUCTS AND THE LIKE AND FOR CURING AND/OR STORAGE ROOMS OF THE SAME PERPRIN S.R.L. (IT) 2019-12-26 WO claimed
EP-3509647-A1 ABSORBENT ARTICLES INCLUDING PERFUME AND CYCLODEXTRINS The Procter and Gamble Company (US) 2019-07-17 EP claimed
WO-2018145219-A1 PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING SERANI MOSTAZAL JORGE (CL) 2018-08-16 WO claimed
WO-2018048852-A1 ABSORBENT ARTICLES INCLUDING PERFUME AND CYCLODEXTRINS THE PROCTER & GAMBLE COMPANY (US) 2018-03-15 WO claimed
US-20180064588-A1 Absorbent Articles Including Perfume and Cyclodextrins THE PROCTER & GAMBLE COMPANY 2018-03-08 US claimed
US-20260102294-A1 ABSORBENT ARTICLE COMPRISING A FRAGRANCE AND AN ODOR CONTROL COMPOSITION PROCTER & GAMBLE (US) 2026-04-16 US disclosed
US-20260069734-A1 FRESHENING COMPOSITIONS COMPRISING CONTROLLED RELEASE MODULATORS ARYLESSENCE INC (US) 2026-03-12 US disclosed
US-12533269-B2 Absorbent article comprising a fragrance and an odor control composition THE PROCTER & GAMBLE COMPANY (US) 2026-01-27 US disclosed
US-12496370-B2 Freshening compositions comprising controlled release modulators Arylessence, Inc. (US) 2025-12-16 US disclosed
US-20070088508-A1 Cocrystallization methods APTUIT (WEST LAFAYETTE), LLC 2007-04-19 US disclosed
WO-2007038524-A2 COCRYSTALLIZATION METHODS SSCI, INC. (US) 2007-04-05 WO disclosed
US-20060165622-A1 Deodorant composition TAKASAGO INTERNATIONAL CORPORATION (JP) 2006-07-27 US disclosed
EP-1561476-A1 DEODORANT COMPOSITION Takasago International Corporation (JP) 2005-08-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12533269-B2 Absorbent article comprising a fragrance and an odor control composition CUTA, CFD, MBTD1 ALDH1A1 1162/4885POLB 584/4885MAPT 647/4885
US-20260102294-A1 ABSORBENT ARTICLE COMPRISING A FRAGRANCE AND AN ODOR CONTROL COMPOSITION CUTA, SHBG, DSG1 ALDH1A1 1516/4885POLB 1914/4885MAPT 1088/4885
US-20260069734-A1 FRESHENING COMPOSITIONS COMPRISING CONTROLLED RELEASE MODULATORS FFAR1, FFAR2, FFAR3 ALDH1A1 697/4885POLB 3246/4885MAPT 4109/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.